Ignite Creation Date:
2024-05-06 @ 12:47 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01657682
Status:
COMPLETED
Last Update Posted:
2023-11-30
First Post:
2012-07-31
Brief Title:
A Phase II Study of Crenolanib in RelapsedRefractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc